GlobeNewswire: NanoString Technologies, Inc. Contains the last 10 of 209 releaseshttp://www.globenewswire.com/External?Length=42024-03-19T03:31:48ZGlobeNewswirehttp://www.globenewswire.com/External?Length=4newsdesk@globenewswire.com (NewsDesk)https://www.globenewswire.com/news-release/2019/08/28/1907590/0/en/NanoString-to-Present-at-the-2019-Morgan-Stanley-Global-Healthcare-Conference.html?f=22&fvtc=4&fvtv=19685NanoString to Present at the 2019 Morgan Stanley Global Healthcare Conference2019-08-28T10:00:00Z<![CDATA[SEATTLE, Aug. 28, 2019 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for translational research and molecular diagnostic products, today announced that the company’s management is scheduled to present at the 2019 Morgan Stanley Global Healthcare Conference in New York City.]]>https://www.globenewswire.com/news-release/2019/08/19/1903384/0/en/NanoString-to-Present-at-the-Baird-2019-Global-Healthcare-Conference.html?f=22&fvtc=4&fvtv=19685NanoString to Present at the Baird 2019 Global Healthcare Conference2019-08-19T10:00:00Z<![CDATA[SEATTLE, Aug. 19, 2019 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for translational research and molecular diagnostic products, today announced that the company’s management is scheduled to present at the Baird 2019 Global Healthcare Conference in New York City.]]>https://www.globenewswire.com/news-release/2019/08/06/1897346/0/en/New-Publication-Demonstrates-First-Use-of-NanoString-s-GeoMx-Digital-Spatial-Profiler-in-Neuroscience.html?f=22&fvtc=4&fvtv=19685New Publication Demonstrates First Use of NanoString’s GeoMx Digital Spatial Profiler in Neuroscience2019-08-06T10:00:00Z<![CDATA[Study Applies Digital Spatial Profiling and nCounter Gene Expression Panels to Illuminate Role of Immune System in Human Alzheimer’s Disease Study Applies Digital Spatial Profiling and nCounter Gene Expression Panels to Illuminate Role of Immune System in Human Alzheimer’s Disease]]>https://www.globenewswire.com/news-release/2019/07/31/1895083/0/en/NanoString-Technologies-Releases-Operating-Results-for-Second-Quarter-of-2019.html?f=22&fvtc=4&fvtv=19685NanoString Technologies Releases Operating Results for Second Quarter of 20192019-07-31T20:01:00Z<![CDATA[SEATTLE, July 31, 2019 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today reported financial results for the second quarter of 2019.]]>https://www.globenewswire.com/news-release/2019/07/30/1893790/0/en/NanoString-Technologies-and-Mayo-Clinic-Laboratories-Enter-Joint-Development-Agreement-to-Develop-Novel-Assays.html?f=22&fvtc=4&fvtv=19685NanoString Technologies and Mayo Clinic Laboratories Enter Joint Development Agreement to Develop Novel Assays2019-07-30T13:29:00Z<![CDATA[SEATTLE and ROCHESTER, Minn., July 30, 2019 (GLOBE NEWSWIRE) -- NanoString Technologies and Mayo Clinic Laboratories have announced a collaboration to develop clinical tests using NanoString's new GeoMx Digital Spatial Profiler. GeoMx combines spatial and molecular profiling technologies by generating a whole tissue image at single cell resolution while also providing digital profiling data for tens to thousands of RNA or protein analytes for up to 16–20 tissue slides per day. This combination of spatial profiling enables researchers to rapidly assess the biological implications within tissue samples.]]>https://www.globenewswire.com/news-release/2019/07/23/1886681/0/en/CORRECTING-and-REPLACING-Nature-Medicine-Publication-Highlights-use-of-the-GeoMx-Digital-Spatial-Profiler-to-Characterize-Mechanism-of-Neurotoxicity-in-Immuno-Therapy.html?f=22&fvtc=4&fvtv=19685CORRECTING and REPLACING - Nature Medicine Publication Highlights use of the GeoMx Digital Spatial Profiler to Characterize Mechanism of Neurotoxicity in Immuno-Therapy 2019-07-23T19:20:05Z<![CDATA[Third Nature Medicine Publication to Include Novel Discoveries Using Digital Spatial Profiling, Sixth Peer-Reviewed Publication to Date Third Nature Medicine Publication to Include Novel Discoveries Using Digital Spatial Profiling, Sixth Peer-Reviewed Publication to Date]]>https://www.globenewswire.com/news-release/2019/07/22/1886029/0/en/Nature-Medicine-Publication-Highlights-use-of-the-GeoMx-Digital-Spatial-Profiler-to-Characterize-Mechanism-of-Neurotoxicity-in-Immuno-Therapy.html?f=22&fvtc=4&fvtv=19685Nature Medicine Publication Highlights use of the GeoMx Digital Spatial Profiler to Characterize Mechanism of Neurotoxicity in Immuno-Therapy 2019-07-22T20:01:00Z<![CDATA[Third Nature Medicine Publication to Include Novel Discoveries Using Digital Spatial Profiling, Sixth Peer-Reviewed Publication to Date Third Nature Medicine Publication to Include Novel Discoveries Using Digital Spatial Profiling, Sixth Peer-Reviewed Publication to Date]]>https://www.globenewswire.com/news-release/2019/07/15/1882433/0/en/NanoString-Collaborates-with-MODEL-AD-Consortium-to-Accelerate-Alzheimer-s-Disease-Research.html?f=22&fvtc=4&fvtv=19685NanoString Collaborates with MODEL-AD Consortium to Accelerate Alzheimer’s Disease Research2019-07-15T10:00:00Z<![CDATA[nCounter Mouse AD Gene Expression Panel Applied to Characterize Five Novel Mouse Models]]>https://www.globenewswire.com/news-release/2019/07/10/1880681/0/en/NanoString-to-Release-Second-Quarter-2019-Financial-Results-and-Host-Conference-Call-on-Wednesday-July-31-2019.html?f=22&fvtc=4&fvtv=19685NanoString to Release Second Quarter 2019 Financial Results and Host Conference Call on Wednesday, July 31, 20192019-07-10T10:00:00Z<![CDATA[SEATTLE, July 10, 2019 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that the Company will release second quarter 2019 financial results after the close of trading on Wednesday, July 31, 2019. Company management will host a conference call beginning at 4:30pm ET to discuss those results and provide a business update.]]>https://www.globenewswire.com/news-release/2019/06/18/1870789/0/en/Publication-in-the-Journal-Clinical-Cancer-Research-Uses-NanoString-s-GeoMx-Digital-Spatial-Profiler-to-Discover-Predictive-Biomarkers-for-Immunotherapy.html?f=22&fvtc=4&fvtv=19685Publication in the Journal Clinical Cancer Research Uses NanoString’s GeoMx Digital Spatial Profiler to Discover Predictive Biomarkers for Immunotherapy2019-06-18T20:01:00Z<![CDATA[Researchers Used GeoMx Digital Spatial Profiler to Identify Biomarkers Predictive for Objective Response, Progression Free Survival and Overall Survival for Melanoma Patients Receiving Immunotherapy Researchers Used GeoMx Digital Spatial Profiler to Identify Biomarkers Predictive for Objective Response, Progression Free Survival and Overall Survival for Melanoma Patients Receiving Immunotherapy]]>